Old | New | Differences | |
---|---|---|---|
1 | - | LAWRENCE J. HOGAN, JR., Governor Ch. 720 | |
2 | 1 | ||
3 | - | – 1 – | |
4 | - | Chapter 720 | |
5 | - | (Senate Bill 19) | |
6 | 2 | ||
7 | - | AN ACT concerning | |
3 | + | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. | |
4 | + | [Brackets] indicate matter deleted from existing law. | |
5 | + | Underlining indicates amendments to bill. | |
6 | + | Strike out indicates matter stricken from the bill by amendment or deleted from the law by | |
7 | + | amendment. | |
8 | + | Italics indicate opposite chamber/conference committee amendments. | |
9 | + | *sb0019* | |
8 | 10 | ||
9 | - | Pharmacists – Administration of Maintenance Injectable Medications – | |
10 | - | Medications for Treatment of Sexually Transmitted Infections | |
11 | + | SENATE BILL 19 | |
12 | + | J2, J1 (2lr1028) | |
13 | + | ENROLLED BILL | |
14 | + | — Education, Health, and Environmental Affairs/Health and Government | |
15 | + | Operations — | |
16 | + | Introduced by Senator Lam | |
11 | 17 | ||
12 | - | FOR the purpose of altering the definition of “maintenance injectable medication” for the | |
13 | - | purposes of provisions of law governing the administration of maintenance injectable | |
14 | - | medications by pharmacists to include a medication that treats a sexually | |
15 | - | transmitted infection and is not a vaccine defining “injectable medications for | |
16 | - | treatment of sexually transmitted infections” for the purposes of authorizing | |
17 | - | pharmacists to administer the medications; requiring certain insurers, nonprofit | |
18 | - | health service plans, health maintenance organizations, the Maryland Medical | |
19 | - | Assistance Program, and the Maryland Children’s Health Program to provide certain | |
20 | - | coverage for the administration of the medication by a pharmacist; and generally | |
21 | - | relating to the administration of maintenance injectable medications by | |
22 | - | pharmacists. | |
18 | + | Read and Examined by Proofreaders: | |
23 | 19 | ||
24 | - | BY repealing and reenacting, with amendments, | |
25 | - | Article – Health Occupations | |
26 | - | Section 12–101(o–1) | |
27 | - | Annotated Code of Maryland | |
28 | - | (2021 Replacement Volume) | |
20 | + | _______________________________________________ | |
21 | + | Proofreader. | |
22 | + | _______________________________________________ | |
23 | + | Proofreader. | |
29 | 24 | ||
30 | - | BY repealing and reenacting, with amendments, | |
31 | - | Article – Health – General | |
32 | - | Section 15–148(c) | |
33 | - | Annotated Code of Maryland | |
34 | - | (2019 Replacement Volume and 2021 Supplement) | |
25 | + | Sealed with the Great Seal and presented to the Governor, for his approval this | |
35 | 26 | ||
36 | - | BY adding to | |
37 | - | Article – Health Occupations | |
38 | - | Section 12–101(l–1) | |
39 | - | Annotated Code of Maryland | |
40 | - | (2021 Replacement Volume) | |
27 | + | _______ day of _______________ at ________________________ o’clock, ________M. | |
41 | 28 | ||
42 | - | BY repealing and reenacting, without with amendments, | |
43 | - | Article – Health Occupations | |
44 | - | Section 12–509(a) and (b) 12–509 | |
45 | - | Annotated Code of Maryland | |
46 | - | (2021 Replacement Volume) | |
29 | + | ______________________________________________ | |
30 | + | President. | |
47 | 31 | ||
48 | - | BY repealing and reenacting, with amendments, | |
49 | - | Article – Insurance Ch. 720 2022 LAWS OF MARYLAND | |
32 | + | CHAPTER ______ | |
50 | 33 | ||
51 | - | – 2 – | |
52 | - | Section 15–716 | |
53 | - | Annotated Code of Maryland | |
54 | - | (2017 Replacement Volume and 2021 Supplement) | |
34 | + | AN ACT concerning 1 | |
55 | 35 | ||
56 | - | ||
57 | - | ||
36 | + | Pharmacists – Administration of Maintenance Injectable Medications – 2 | |
37 | + | Medications for Treatment of Sexually Transmitted Infections 3 | |
58 | 38 | ||
59 | - | Article – Health – General | |
39 | + | FOR the purpose of altering the definition of “maintenance injectable medication” for the 4 | |
40 | + | purposes of provisions of law governing the administration of maintenance injectable 5 | |
41 | + | medications by pharmacists to include a medication that treats a sexually 6 | |
42 | + | transmitted infection and is not a vaccine defining “injectable medications for 7 | |
43 | + | treatment of sexually transmitted infections” for the purposes of authorizing 8 | |
44 | + | pharmacists to administer the medications; requiring certain insurers, nonprofit 9 | |
45 | + | health service plans, health maintenance organizations, the Maryland Medical 10 | |
46 | + | Assistance Program, and the Maryland Children’s Health Program to provide certain 11 | |
47 | + | coverage for the administration of the medication by a pharmacist; and generally 12 | |
48 | + | relating to the administration of maintenance injectable medications by 13 | |
49 | + | pharmacists. 14 2 SENATE BILL 19 | |
60 | 50 | ||
61 | - | 15–148. | |
62 | 51 | ||
63 | - | (c) The Program and the Maryland Children’s Health Program shall provide | |
64 | - | coverage for services, to the same extent as services rendered by any other licensed health | |
65 | - | care practitioner, rendered to an enrollee by a licensed pharmacist under: | |
66 | 52 | ||
67 | - | (1) § 12–509 of the Health Occupations Article in administering | |
68 | - | self–administered medications [or], maintenance injectable medications, OR INJECTABLE | |
69 | - | MEDICATIONS FOR TREA TMENT OF SEXUALLY TR ANSMITTED INFECTIONS ; or | |
53 | + | BY repealing and reenacting, with amendments, 1 | |
54 | + | Article – Health Occupations 2 | |
55 | + | Section 12–101(o–1) 3 | |
56 | + | Annotated Code of Maryland 4 | |
57 | + | (2021 Replacement Volume) 5 | |
70 | 58 | ||
71 | - | (2) § 12–511 of the Health Occupations Article in screening an enrollee and | |
72 | - | prescribing contraceptives for the enrollee. | |
59 | + | BY repealing and reenacting, with amendments, 6 | |
60 | + | Article – Health – General 7 | |
61 | + | Section 15–148(c) 8 | |
62 | + | Annotated Code of Maryland 9 | |
63 | + | (2019 Replacement Volume and 2021 Supplement) 10 | |
73 | 64 | ||
74 | - | Article – Health Occupations | |
65 | + | BY adding to 11 | |
66 | + | Article – Health Occupations 12 | |
67 | + | Section 12–101(l–1) 13 | |
68 | + | Annotated Code of Maryland 14 | |
69 | + | (2021 Replacement Volume) 15 | |
75 | 70 | ||
76 | - | 12–101. | |
71 | + | BY repealing and reenacting, without with amendments, 16 | |
72 | + | Article – Health Occupations 17 | |
73 | + | Section 12–509(a) and (b) 12–509 18 | |
74 | + | Annotated Code of Maryland 19 | |
75 | + | (2021 Replacement Volume) 20 | |
77 | 76 | ||
78 | - | (o–1) (1) “Maintenance injectable medication” means a medication that: | |
77 | + | BY repealing and reenacting, with amendments, 21 | |
78 | + | Article – Insurance 22 | |
79 | + | Section 15–716 23 | |
80 | + | Annotated Code of Maryland 24 | |
81 | + | (2017 Replacement Volume and 2021 Supplement) 25 | |
79 | 82 | ||
80 | - | (i) Is administered by injection other than intravenously; and | |
83 | + | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 26 | |
84 | + | That the Laws of Maryland read as follows: 27 | |
81 | 85 | ||
82 | - | ||
86 | + | Article – Health – General 28 | |
83 | 87 | ||
84 | - | 2. TREATS A SEXUALLY TRA NSMITTED INFECTION A ND | |
85 | - | IS NOT A VACCINE . | |
88 | + | 15–148. 29 | |
86 | 89 | ||
87 | - | (2) “Maintenance injectable medication” includes a medication for the | |
88 | - | treatment of a psychiatric disorder or substance use disorder, contraception, and vitamins. | |
90 | + | (c) The Program and the Maryland Children’s Health Program shall provide 30 | |
91 | + | coverage for services, to the same extent as services rendered by any other licensed health 31 | |
92 | + | care practitioner, rendered to an enrollee by a licensed pharmacist under: 32 | |
89 | 93 | ||
90 | - | (L–1) “INJECTABLE MEDICATION FOR TREATMENT OF A S EXUALLY | |
91 | - | TRANSMITTED INFECTIO N” MEANS A MEDICATION T HAT: | |
94 | + | (1) § 12–509 of the Health Occupations Article in administering 33 | |
95 | + | self–administered medications [or], maintenance injectable medications, OR INJECTABLE 34 | |
96 | + | MEDICATIONS FOR TREA TMENT OF SEXUALLY TR ANSMITTED INFECTIONS ; or 35 | |
97 | + | SENATE BILL 19 3 | |
92 | 98 | ||
93 | - | (1) IS ADMINISTERED BY IN JECTION OTHER THAN I NTRAVENOUSLY ; | |
94 | 99 | ||
95 | - | (2) | |
96 | - | ||
100 | + | (2) § 12–511 of the Health Occupations Article in screening an enrollee and 1 | |
101 | + | prescribing contraceptives for the enrollee. 2 | |
97 | 102 | ||
98 | - | – 3 – | |
99 | - | (3) IS NOT A VACCINE. | |
103 | + | Article – Health Occupations 3 | |
100 | 104 | ||
101 | - | 12– | |
105 | + | 12–101. 4 | |
102 | 106 | ||
103 | - | (a) In addition to the authority granted to a pharmacist under § 12–508 of this | |
104 | - | subtitle, a pharmacist, in accordance with regulations adopted by the Board, may | |
105 | - | administer: | |
107 | + | (o–1) (1) “Maintenance injectable medication” means a medication that: 5 | |
106 | 108 | ||
107 | - | (1) A self–administered drug to a patient that is prescribed by an | |
108 | - | authorized prescriber; and | |
109 | + | (i) Is administered by injection other than intravenously; and 6 | |
109 | 110 | ||
110 | - | (2) Subject to subsection (b) of this section, a maintenance injectable | |
111 | - | medication OR AN INJECTABLE MED ICATION FOR TREATMEN T OF A SEXUALLY | |
112 | - | TRANSMITTED INFECTIO N that is not a biological product to a patient: | |
111 | + | (ii) 1. Treats a chronic need, condition, or disorder; OR 7 | |
113 | 112 | ||
114 | - | (i) That is prescribed by an authorized prescriber; | |
113 | + | 2. TREATS A SEXUALLY TRA NSMITTED INFECTION A ND 8 | |
114 | + | IS NOT A VACCINE. 9 | |
115 | 115 | ||
116 | - | ( | |
117 | - | ||
116 | + | (2) “Maintenance injectable medication” includes a medication for the 10 | |
117 | + | treatment of a psychiatric disorder or substance use disorder, contraception, and vitamins. 11 | |
118 | 118 | ||
119 | - | (iii) In accordance with a protocol under Subtitle 6A of this title. | |
119 | + | (L–1) “INJECTABLE MEDICATION FOR TREATMENT OF A S EXUALLY 12 | |
120 | + | TRANSMITTED INFECTIO N” MEANS A MEDICATION T HAT: 13 | |
120 | 121 | ||
121 | - | (b) A pharmacist may not administer an initial dose of a maintenance injectable | |
122 | - | medication product OR AN INJECTABLE MED ICATION FOR TREATMEN T OF A SEXUALLY | |
123 | - | TRANSMITTED INFECTIO N under subsection (a)(2) of this section unless the pharmacist | |
124 | - | receives written approval from the prescriber. | |
122 | + | (1) IS ADMINISTERED BY IN JECTION OTHER THAN I NTRAVENOUSLY ; 14 | |
125 | 123 | ||
126 | - | (c) (1) On or before September 1, 2021, the Board, in consultation with the | |
127 | - | State Board of Physicians and the State Board of Nursing, shall adopt regulations | |
128 | - | establishing standard procedures: | |
124 | + | (2) TREATS A SEXUALLY TRANSMITTED INFECTIO N; AND 15 | |
129 | 125 | ||
130 | - | (i) For notifying a patient about payment for services before the | |
131 | - | pharmacist administers a maintenance injectable medication OR AN INJECTABLE | |
132 | - | MEDICATION FOR TREAT MENT OF A SEXUALLY T RANSMITTED INFECTION ; | |
126 | + | (3) IS NOT A VACCINE. 16 | |
133 | 127 | ||
134 | - | ||
128 | + | 12–509. 17 | |
135 | 129 | ||
136 | - | 1. A maintenance injectable medication after an initial dose | |
137 | - | is administered by the prescriber; OR | |
130 | + | (a) In addition to the authority granted to a pharmacist under § 12–508 of this 18 | |
131 | + | subtitle, a pharmacist, in accordance with regulations adopted by the Board, may 19 | |
132 | + | administer: 20 | |
138 | 133 | ||
139 | - | | |
140 | - | ||
134 | + | (1) A self–administered drug to a patient that is prescribed by an 21 | |
135 | + | authorized prescriber; and 22 | |
141 | 136 | ||
142 | - | (iii) That a pharmacist must use to administer an initial dose of a | |
143 | - | maintenance injectable medication OR AN INJECTABLE MED ICATION FOR TREATMEN T Ch. 720 2022 LAWS OF MARYLAND | |
137 | + | (2) Subject to subsection (b) of this section, a maintenance injectable 23 | |
138 | + | medication OR AN INJECTABLE MED ICATION FOR TREATMEN T OF A SEXUALLY 24 | |
139 | + | TRANSMITTED INFECTIO N that is not a biological product to a patient: 25 | |
144 | 140 | ||
145 | - | – 4 – | |
146 | - | OF A SEXUALLY TRANSM ITTED INFECTION if the administration of the initial dose is | |
147 | - | authorized under subsection (b) of this section; and | |
141 | + | (i) That is prescribed by an authorized prescriber; 26 | |
148 | 142 | ||
149 | - | (iv) For communicating to the prescriber whether a medication was | |
150 | - | administered to a specific patient and relevant information about the patient’s condition. | |
143 | + | (ii) In accordance with a standing order issued by an authorized 27 | |
144 | + | public health official; or 28 | |
145 | + | 4 SENATE BILL 19 | |
151 | 146 | ||
152 | - | (2) The regulations shall require a pharmacist to: | |
153 | 147 | ||
154 | - | (i) Except as provided in paragraph (3) of this subsection, complete | |
155 | - | a training program approved by the Board for: | |
148 | + | (iii) In accordance with a protocol under Subtitle 6A of this title. 1 | |
156 | 149 | ||
157 | - | 1. Administering maintenance injectable medications AND | |
158 | - | INJECTABLE MEDICATIO NS FOR TREATMENT OF A SEXUALLY TRANSMITT ED | |
159 | - | INFECTION; and | |
150 | + | (b) A pharmacist may not administer an initial dose of a maintenance injectable 2 | |
151 | + | medication product OR AN INJECTABLE MED ICATION FOR TREATMEN T OF A SEXUALLY 3 | |
152 | + | TRANSMITTED INFECTIO N under subsection (a)(2) of this section unless the pharmacist 4 | |
153 | + | receives written approval from the prescriber. 5 | |
160 | 154 | ||
161 | - | | |
162 | - | ||
163 | - | ||
155 | + | (c) (1) On or before September 1, 2021, the Board, in consultation with the 6 | |
156 | + | State Board of Physicians and the State Board of Nursing, shall adopt regulations 7 | |
157 | + | establishing standard procedures: 8 | |
164 | 158 | ||
165 | - | (ii) Follow the standard procedures established by the Board; and | |
159 | + | (i) For notifying a patient about payment for services before the 9 | |
160 | + | pharmacist administers a maintenance injectable medication OR AN INJECTABLE 10 | |
161 | + | MEDICATION FOR TREAT MENT OF A SEXUALLY T RANSMITTED INFECTION ; 11 | |
166 | 162 | ||
167 | - | (iii) After administering a maintenance injectable medication OR AN | |
168 | - | INJECTABLE MEDICATIO N FOR TREA TMENT OF A SEXUALLY TRANSMITTED | |
169 | - | INFECTION: | |
163 | + | (ii) That a pharmacist must use to administer [a]: 12 | |
170 | 164 | ||
171 | - | 1. Notify the prescriber that the maintenance injectable | |
172 | - | medication OR INJECTABLE MEDICA TION FOR TREATMENT O F A SEXUALLY | |
173 | - | TRANSMITTED INFECTIO N was administered and of any relevant details about the | |
174 | - | patient’s condition; | |
165 | + | 1. A maintenance injectable medication after an initial dose 13 | |
166 | + | is administered by the prescriber; OR 14 | |
175 | 167 | ||
176 | - | 2. Provide the patient with a written record of the | |
177 | - | maintenance injectable medication OR INJECTABLE MEDICA TION FOR TREATMENT O F A | |
178 | - | SEXUALLY TRANSMITTED INFECTION administered; | |
168 | + | 2. AN INJECTABLE MEDICAT ION FOR TREATMENT OF A 15 | |
169 | + | SEXUALLY TRANSMITTED INFECTION; 16 | |
179 | 170 | ||
180 | - | 3. Record in any electronic or written health record on the | |
181 | - | patient maintained by the pharmacist: | |
171 | + | (iii) That a pharmacist must use to administer an initial dose of a 17 | |
172 | + | maintenance injectable medication OR AN INJECTABLE MED ICATION FOR TREATMEN T 18 | |
173 | + | OF A SEXUALLY TRANSM ITTED INFECTION if the administration of the initial dose is 19 | |
174 | + | authorized under subsection (b) of this section; and 20 | |
182 | 175 | ||
183 | - | A. The administering of the maintenance injectable | |
184 | - | medication OR INJECTABLE MEDICA TION FOR TREATMENT O F A SEXUALLY | |
185 | - | TRANSMITTED INFECTIO N; and | |
176 | + | (iv) For communicating to the prescriber whether a medication was 21 | |
177 | + | administered to a specific patient and relevant information about the patient’s condition. 22 | |
186 | 178 | ||
187 | - | | |
179 | + | (2) The regulations shall require a pharmacist to: 23 | |
188 | 180 | ||
189 | - | | |
190 | - | ||
181 | + | (i) Except as provided in paragraph (3) of this subsection, complete 24 | |
182 | + | a training program approved by the Board for: 25 | |
191 | 183 | ||
192 | - | – 5 – | |
184 | + | 1. Administering maintenance injectable medications AND 26 | |
185 | + | INJECTABLE MEDICATIO NS FOR TREATMENT OF A SEXUALLY TRANSMITT ED 27 | |
186 | + | INFECTION; and 28 | |
193 | 187 | ||
194 | - | | |
195 | - | ||
196 | - | ||
188 | + | 2. Managing the populations the pharmacist serves, the 29 | |
189 | + | medications being administered, and the current guidelines relating to these populations 30 | |
190 | + | and medications; 31 | |
197 | 191 | ||
198 | - | Article – Insurance | |
192 | + | (ii) Follow the standard procedures established by the Board; and 32 | |
193 | + | SENATE BILL 19 5 | |
199 | 194 | ||
200 | - | 15–716. | |
201 | 195 | ||
202 | - | (a) This section applies to individual, group, or blanket health insurance policies | |
203 | - | and contracts delivered or issued for delivery in the State by insurers, nonprofit health | |
204 | - | service plans, and health maintenance organizations that provide coverage for patient | |
205 | - | assessment regarding, and administration of, self–administered medications [and], | |
206 | - | maintenance injectable medications, AND INJECTABLE MEDIC ATIONS FOR TREATMENT | |
207 | - | OF SEXUALLY TRANSMIT TED INFECTIONS . | |
196 | + | (iii) After administering a maintenance injectable medication OR AN 1 | |
197 | + | INJECTABLE MEDICATIO N FOR TREATMENT OF A SEXUALLY TRANSMITTED 2 | |
198 | + | INFECTION: 3 | |
208 | 199 | ||
209 | - | (b) An entity subject to this section shall provide coverage for services rendered by | |
210 | - | a licensed pharmacist under § 12–509 of the Health Occupations Article to an individual | |
211 | - | who is covered under a policy or contract issued or delivered by the entity, to the same extent | |
212 | - | as services rendered by any other licensed health care practitioner, for patient assessment | |
213 | - | regarding and in administering self–administered medications [or], maintenance injectable | |
214 | - | medications, OR INJECTABLE MEDICA TIONS FOR TREATMENT OF SEXUALLY | |
215 | - | TRANSMITTED INFECTIO NS. | |
200 | + | 1. Notify the prescriber that the maintenance injectable 4 | |
201 | + | medication OR INJECTABLE MEDICA TION FOR TREATMENT O F A SEXUALLY 5 | |
202 | + | TRANSMITTED INFECTIO N was administered and of any relevant details about the 6 | |
203 | + | patient’s condition; 7 | |
216 | 204 | ||
217 | - | SECTION 2. AND BE IT FURTHER ENACTED, That, to the extent determined | |
218 | - | appropriate by the State Board of Pharmacy, the regulations adopted by the State Board of | |
219 | - | Pharmacy, in consultation with the State Board of Physicians and the State Board of | |
220 | - | Nursing, under § 12–509 of the Health Occupations Article, as enacted by Chapters 757 and | |
221 | - | 758 of the Acts of the General Assembly of 2021, for the administration of maintenance | |
222 | - | injectable medications by a pharmacist shall be the same regulations for the administration | |
223 | - | of injectable medications for treatment of sexually transmitted infections by a pharmacist | |
224 | - | adopted in accordance with § 12–509 of the Health Occupations Article, as enacted by this | |
225 | - | Act. | |
205 | + | 2. Provide the patient with a written record of the 8 | |
206 | + | maintenance injectable medication OR INJECTABLE MEDICA TION FOR TREATMENT O F A 9 | |
207 | + | SEXUALLY TRANSMITTED INFECTION administered; 10 | |
226 | 208 | ||
227 | - | ||
228 | - | ||
209 | + | 3. Record in any electronic or written health record on the 11 | |
210 | + | patient maintained by the pharmacist: 12 | |
229 | 211 | ||
230 | - | Enacted under Article II, § 17(c) of the Maryland Constitution, May 29, 2022. | |
212 | + | A. The administering of the maintenance injectable 13 | |
213 | + | medication OR INJECTABLE MEDICA TION FOR TREATMENT O F A SEXUALLY 14 | |
214 | + | TRANSMITTED INFECTIO N; and 15 | |
215 | + | ||
216 | + | B. Any pertinent details about the patient’s condition; and 16 | |
217 | + | ||
218 | + | 4. Notify the patient of the need to attend any upcoming 17 | |
219 | + | appointments the patient has scheduled with the prescriber. 18 | |
220 | + | ||
221 | + | (3) The regulations shall waive the requirement to complete a training 19 | |
222 | + | program for a pharmacist who already has undergone the training as part of the 20 | |
223 | + | pharmacist’s formal educational program. 21 | |
224 | + | ||
225 | + | Article – Insurance 22 | |
226 | + | ||
227 | + | 15–716. 23 | |
228 | + | ||
229 | + | (a) This section applies to individual, group, or blanket health insurance policies 24 | |
230 | + | and contracts delivered or issued for delivery in the State by insurers, nonprofit health 25 | |
231 | + | service plans, and health maintenance organizations that provide coverage for patient 26 | |
232 | + | assessment regarding, and administration of, self–administered medications [and], 27 | |
233 | + | maintenance injectable medications, AND INJECTABLE MEDIC ATIONS FOR TREATMENT 28 | |
234 | + | OF SEXUALLY TRANSMIT TED INFECTIONS . 29 | |
235 | + | ||
236 | + | (b) An entity subject to this section shall provide coverage for services rendered by 30 | |
237 | + | a licensed pharmacist under § 12–509 of the Health Occupations Article to an individual 31 | |
238 | + | who is covered under a policy or contract issued or delivered by the entity, to the same extent 32 | |
239 | + | as services rendered by any other licensed health care practitioner, for patient assessment 33 | |
240 | + | regarding and in administering self–administered medications [or], maintenance injectable 34 6 SENATE BILL 19 | |
241 | + | ||
242 | + | ||
243 | + | medications, OR INJECTABLE MEDICA TIONS FOR TREATMENT OF SEXUALLY 1 | |
244 | + | TRANSMITTED INFECTIO NS. 2 | |
245 | + | ||
246 | + | SECTION 2. AND BE IT FURTHER ENACTED, That, to the extent determined 3 | |
247 | + | appropriate by the State Board of Pharmacy, the regulations adopted by the State Board of 4 | |
248 | + | Pharmacy, in consultation with the State Board of Physicians and the State Board of 5 | |
249 | + | Nursing, under § 12–509 of the Health Occupations Article, as enacted by Chapters 757 and 6 | |
250 | + | 758 of the Acts of the General Assembly of 2021, for the administration of maintenance 7 | |
251 | + | injectable medications by a pharmacist shall be the same regulations for the administration 8 | |
252 | + | of injectable medications for treatment of sexually transmitted infections by a pharmacist 9 | |
253 | + | adopted in accordance with § 12–509 of the Health Occupations Article, as enacted by this 10 | |
254 | + | Act. 11 | |
255 | + | ||
256 | + | SECTION 2. 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 12 | |
257 | + | October 1, 2022. 13 | |
258 | + | ||
259 | + | ||
260 | + | ||
261 | + | ||
262 | + | Approved: | |
263 | + | ________________________________________________________________________________ | |
264 | + | Governor. | |
265 | + | ________________________________________________________________________________ | |
266 | + | President of the Senate. | |
267 | + | ________________________________________________________________________________ | |
268 | + | Speaker of the House of Delegates. |